Bellerophon Therapeutics | 15-12G:終止註冊
03/06 11:34 (美東)
Bellerophon Therapeutics | 8-K:重大事件
03/04 17:55 (美東)
Bellerophon Therapeutics | SCHEDULE 13G:其他
03/01 10:09 (美東)
Bellerophon Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(0.0%),Joseph Edelman(0.0%)等
02/14 16:55 (美東)
Bellerophon Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(0.0%),Tang Capital Management, LLC(0.0%)等
02/14 16:03 (美東)
Bellerophon Therapeutics | DEFA14A:其他
02/12 15:50 (美東)
Bellerophon Therapeutics | DEFA14A:其他
02/12 12:40 (美東)
Bellerophon Therapeutics | 8-K:重大事件
01/30 09:32 (美東)
Bellerophon Therapeutics | SCHEDULE 13G:其他
01/26 14:35 (美東)
Bellerophon Therapeutics | SC 13G:超過5%持股股東披露文件-507 Summit LLC(8.4%),Lepercq Capital Management LLC(8.4%)等
01/26 10:49 (美東)
Bellerophon Therapeutics | 8-K:重大事件
01/22 00:00 (美東)
Bellerophon Therapeutics | 8-K:重大事件
01/10 00:00 (美東)
Bellerophon Therapeutics | DEFA14A:其他
01/03 00:00 (美東)
Bellerophon Therapeutics | 25-NSE:由交易所申報的註銷已到期、已贖回、已兌付證券的通知
2023/12/27 00:00 (美東)
Bellerophon Therapeutics | 8-K:重大事件
2023/12/12 16:10 (美東)
Bellerophon Therapeutics | 8-K:重大事件
2023/11/21 16:05 (美東)
Bellerophon Therapeutics:2023財年三季報
2023/11/14 16:31 (美東)
Bellerophon Therapeutics | DEF 14A:股東委託書決議
2023/11/06 16:30 (美東)
Bellerophon Therapeutics | PRE 14A:並購重組委托聲明
2023/10/27 10:50 (美東)
Bellerophon Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Theodore Wang(0.5%),Puissance Life Science Opportunities Fund VI(0%)等
2023/10/17 21:05 (美東)
暫無數據
暫無數據